References
- American Society of Clinical Oncology. Recommendation for the use of hematopoietic edemy-stimu-lating factors: evidence-based, clinical practice guidelines. J Clin Oncol 1994; 12: 2471–2508.
- Gabrilove JL, Jakubowski A, Scher H, et al. Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. N Engl J Med 1988; 318: 1414–1422.
- Antman KS, Griffin JD, Elias A, et al. Effect of recom-binant human granulocyte-macrophage colony-stimulating factor in chemotherapy-induced myelosuppression. N Engl J Med 1988; 319: 593–598.
- Sheridan WP, Morstyn G, Wolf M, et al. Granulocyte colony stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplanta-tion. Lancet 1989; 2: 891–895.
- Taylor KM, Jagannath S, Spitzer G, et al. Recombinant human granulocyte colony stimulating factor hastens granulo-cyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 1989; 7: 1791–1799.
- Grem JL, McAtee N, Murphy RF, et al. Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gas-trointestinal adenocarcinoma. J Clin Oncol 1994; 12: 560–568.
- Merlano M, Vitale V, Rosso R, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992; 327: 1115–1121.
- Merlano M, Benasso M, Cory() R et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy campared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996; 88: 581–583.
- Kwan-Hwa Chi, Chen-Hsin Chen, Wing-Kai Chan et al. Effect of granulocyte-macrophage colony-stimulating factor in head and neck cancer patients after cisplatin, fluorouracil and leucovorin chemotherapy. J Clin Oncol 1995; 13: 2620–2628.